These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38109857)

  • 1. A Case Report of Infant-Type Hemispheric Glioma with a Novel GAB1-ABL2 Kinase Fusion Treated with Dasatinib.
    Buckner-Wolfson E; Jung G; Kim T; Fatemi R; Liriano G; Dalvi N; Behbahani M; Chin S; Martin A; Kobets A
    Pediatr Neurosurg; 2024; 59(1):27-34. PubMed ID: 38109857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Infant-Type Hemispheric Glioma With SOX5::ALK: A Novel Fusion.
    Tsai CC; Huang MH; Fang CL; Hsieh KL; Hsieh TH; Ho WL; Chang H; Tsai ML; Kao YC; Miser JS; Wong TT; Su MY; Liu YL
    J Natl Compr Canc Netw; 2024 Feb; 22(1):. PubMed ID: 38394779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-institutional series of a novel, recurrent TRIM24::MET fusion-driven infant-type hemispheric glioma reveals significant clinico-pathological heterogeneity.
    Gorodezki D; Chiang J; Viaene AN; Sievers P; Schmid S; Holzer U; Paulsen F; Schuhmann MU; Witt O; Schittenhelm J; Ebinger M
    Acta Neuropathol Commun; 2024 Jun; 12(1):101. PubMed ID: 38902810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tyrosine kinase receptor gene fusion: A series of four cases of infantile-type hemispheric glioma].
    Sourty B; Basset L; Michalak S; Colin E; Zidane-Marinnes M; Delion M; de Carli E; Rousseau A
    Ann Pathol; 2023 Nov; 43(6):462-474. PubMed ID: 37635016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience.
    Chiang J; Bagchi A; Li X; Dhanda SK; Huang J; Pinto SN; Sioson E; Dalton J; Tatevossian RG; Jia S; Partap S; Fisher PG; Bowers DC; Hassall TEG; Lu C; Zaldivar-Peraza A; Wright KD; Broniscer A; Qaddoumi I; Upadhyaya SA; Vinitsky A; Sabin ND; Orr BA; Klimo P; Boop FA; Ashford JM; Conklin HM; Onar-Thomas A; Zhou X; Ellison DW; Gajjar A; Robinson GW
    Neuro Oncol; 2024 Jan; 26(1):178-190. PubMed ID: 37503880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
    Tauziède-Espariat A; Beccaria K; Dangouloff-Ros V; Sievers P; Meurgey A; Pissaloux D; Appay R; Saffroy R; Grill J; Mariet C; Bourdeaut F; Hasty L; Métais A; Chrétien F; Blauwblomme T; Puget S; Boddaert N; Varlet P;
    Brain Pathol; 2023 Sep; 33(5):e13182. PubMed ID: 37349135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Unique Case Report of Infant-Type Hemispheric Glioma (Gliosarcoma Subtype) with TPR-NTRK1 Fusion Treated with Larotrectinib.
    Mançano BM; Dos Reis MB; Moreno DA; de Paula FE; de Almeida Junior CR; Cavalcante CEB; Zanon MF; Santana IVV; Matsushita MM; Reis RM
    Pathobiology; 2022; 89(3):178-185. PubMed ID: 35034013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel
    Deland L; Keane S; Bontell TO; Fagman H; Sjögren H; Lind AE; Carén H; Tisell M; Nilsson JA; Ejeskär K; Sabel M; Abel F
    Cancer Genomics Proteomics; 2022; 19(6):711-726. PubMed ID: 36316040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a rare
    Deland L; Keane S; Olsson Bontell T; Sjögren H; Fagman H; Øra I; De La Cuesta E; Tisell M; Nilsson JA; Ejeskär K; Sabel M; Abel F
    Cancer Biol Ther; 2021 Mar; 22(3):184-195. PubMed ID: 33820494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib.
    Shahab SW; Schniederjan M; Vega JV; Little S; Reisner A; MacDonald T; Aguilera D
    Front Oncol; 2023; 13():1123378. PubMed ID: 36910660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorlatinib for ALK-fused, infant-type hemispheric glioma with lung metastasis: a case report.
    Lai M; Li S; Li H; Hu Q; Li J; Zhou J; Ai R; Zhen J; Zhou Z; Wang L; Zhang Y; Hu W; Yuan L; Ma X; Zhang X; Song C; Li Z; Cai L
    Ann Clin Transl Neurol; 2023 May; 10(5):836-841. PubMed ID: 37000961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.
    den Boer ML; Cario G; Moorman AV; Boer JM; de Groot-Kruseman HA; Fiocco M; Escherich G; Imamura T; Yeoh A; Sutton R; Dalla-Pozza L; Kiyokawa N; Schrappe M; Roberts KG; Mullighan CG; Hunger SP; Vora A; Attarbaschi A; Zaliova M; Elitzur S; Cazzaniga G; Biondi A; Loh ML; Pieters R;
    Lancet Haematol; 2021 Jan; 8(1):e55-e66. PubMed ID: 33357483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.
    Truffaux N; Philippe C; Paulsson J; Andreiuolo F; Guerrini-Rousseau L; Cornilleau G; Le Dret L; Richon C; Lacroix L; Puget S; Geoerger B; Vassal G; Östman A; Grill J
    Neuro Oncol; 2015 Jul; 17(7):953-64. PubMed ID: 25534822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the ABL2/ARG kinase in complex with dasatinib.
    Ha BH; Simpson MA; Koleske AJ; Boggon TJ
    Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):443-8. PubMed ID: 25849507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and epigenomic re-categorization of congenital glioblastoma and desmoplastic infantile ganglioglioma.
    Gilani A; Siddiq Z; Kissell E; Kasson J; Kleinschmidt-DeMasters BK
    Childs Nerv Syst; 2023 Jul; 39(7):1861-1868. PubMed ID: 36707425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case report.
    AlJohani NI; Carette S; Lipton JH
    J Med Case Rep; 2015 Sep; 9():214. PubMed ID: 26376827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib for chronic myelomonocytic leukemia with ZMIZ1-ABL1 fusion gene: a case report.
    Liu H; Bai H; Zhang S; Zhao X; Mao D; Xi R
    Int J Hematol; 2023 Jun; 117(6):929-932. PubMed ID: 36694063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
    Tan KW; Zhu YY; Qiu QC; Wang M; Shen HJ; Huang SM; Cao HY; Wan CL; Li YY; Dai HP; Xue SL
    Ann Hematol; 2023 Sep; 102(9):2397-2402. PubMed ID: 37103615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors--a single center experience.
    Ribeiro BF; Miranda EC; Albuquerque DM; Delamain MT; Oliveira-Duarte G; Almeida MH; Vergílio B; Silveira RA; Oliveira-Duarte V; Lorand-Metze I; De Souza CA; Pagnano KB
    Clinics (Sao Paulo); 2015 Aug; 70(8):550-5. PubMed ID: 26247667
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.